As a member of our Drug Safety Evaluation Quality team, your role would be to execute the tasks of New Product Introduction (NPI) Program for XDC’s development projects and manufacturing facilities/sites. 61 As Staff of Drug Safety Evaluation, lead and support the preparation of risk evaluation documents for XDC facilities/sites involved with highly toxic and highly active products including (but not limited to) EHS, NPI program, collinear production (including shared equipment and/or shared facilities), the production of conjugates and other relevant risk assessment to ensure accuracy, scientific soundness, and regulatory appropriateness. 61 Represent as Staff of Drug Safety Evaluation on cross-functional project teams with both internal and external stakeholders. 61 Maintain and update SOPs of New Product Introduction program for the production of Payload-linker, Drug Substance (DS) and Drug Product (DP). 61 Collaborate with XDC PM and CMC teams for training and consultation.